<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65440">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01893138</url>
  </required_header>
  <id_info>
    <org_study_id>13-003</org_study_id>
    <nct_id>NCT01893138</nct_id>
  </id_info>
  <brief_title>Autologous Muscle Derived Cells for Female Urinary Sphincter Repair</brief_title>
  <official_title>A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, double-blind, placebo-controlled, multicenter, confirmatory study will
      evaluate the efficacy and safety of Cook MyoSite Incorporated Autologous Muscle Derived
      Cells for Urinary Sphincter Repair (AMDC-USR) compared to a placebo (vehicle) control dose
      in the treatment of stress urinary incontinence (SUI) in adult female patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of leaks due to stress incontinence episodes, as recorded in a diary</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stress leak frequency and pad weight composite endpoint</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">267</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Roll-in</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Roll-in patients are allowed in the study (up to 3 per investigator) and are randomized and treated exactly the same as standard study patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>AMDC for USR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Roll-in</intervention_name>
    <description>Placebo control is the vehicle solution used for the study product, AMDC for USR is the study product (autologous muscle derived cells for urinary sphincter repair).</description>
    <arm_group_label>Roll-in</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo control is the vehicle solution used for the study product.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>AMDC for USR</intervention_name>
    <description>AMDC for USR is the study product (autologous muscle derived cells for urinary sphincter repair).</description>
    <arm_group_label>AMDC for USR</arm_group_label>
    <other_name>Autologous muscle derived cells for urinary sphincter repair</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patient has primary symptoms of SUI, as confirmed by patient medical history
             and clinical symptoms, including a focused incontinence evaluation.

        Exclusion Criteria:

          -  Patient has symptoms of pure urge incontinence as confirmed by basic evaluation of
             etiology from a patient medical history, including a focused incontinence history.

          -  Patient has symptoms of mixed urinary incontinence where urge incontinence is the
             predominant factor.

          -  Patient has had stress urinary incontinence symptoms less than 6 months prior to
             signing the informed consent.

          -  Patient has not previously attempted conservative treatment prior to signing the
             informed consent.  (Examples of conservative treatment include behavior
             modifications, bladder exercises, biofeedback, etc.)

          -  Patient has more than 2 episode of awakening to void during normal sleeping hours.

          -  Patient cannot be maintained on a stable dose and/or frequency of medication
             (including diuretics) known to affect lower urinary tract function, including but not
             limited to, anticholinergics, tricyclic antidepressants or alpha-adrenergic blockers,
             for at least 2 weeks prior to randomization or is likely to change during the course
             of the study.

          -  Patient is pregnant, lactating, or plans to become pregnant during the course of the
             study.

          -  Patient refuses to provide written informed consent.

          -  Patient is not at least 18 years of age.

          -  Patient is not available for the follow-up evaluations as required by the protocol.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melissa Kaufman, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center, Department of Urologic Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chris Ballas, Ph.D.</last_name>
    <phone>765-463-7537</phone>
    <email>cballas@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Group</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jennifer T Anger, MD</last_name>
      <phone>310-385-2992</phone>
      <email>Jennifer.anger@cshs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Sokol, MD</last_name>
      <phone>650-725-5986</phone>
      <email>esokol@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guillermo Davila, MD</last_name>
      <phone>954-659-5559</phone>
      <email>davilag@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Midtown Urology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenelle Foote, MD</last_name>
      <phone>404-881-0966</phone>
      <email>doctors@midtown-urology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Sand, MD</last_name>
      <phone>224-251-3493</phone>
      <email>psand@northshore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Female Pelvic Medicine &amp; Urogynecology Institute of Michigan</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Bennett, MD</last_name>
      <phone>616-588-1800</phone>
      <email>Chaku73@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Peters, MD</last_name>
      <phone>248-551-0387</phone>
      <email>kmpeters@beaumont.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NYU Urology Associates</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Victor Nitti, MD</last_name>
      <phone>646-825-6328</phone>
      <email>victor.nitti@nyumc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Premier Medical Group of the Hudson Valley PC</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Katz, MD</last_name>
      <phone>845-437-5002</phone>
      <email>DKatzuro@live.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McKay Urology</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Kennelly, MD</last_name>
      <phone>704-355-8686</phone>
      <email>Michael.kennelly@carolinashealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Urology Group</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Igor Dumbadze</last_name>
      <phone>513-841-7550</phone>
      <email>idumbadze@theurologygroup.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mickey Karram, MD</last_name>
      <phone>513-463-2509</phone>
      <email>Mickey.karram@thechristhospital.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Goldman, MD</last_name>
      <phone>216-445-5121</phone>
      <email>goldmah@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikio Nihira, MD</last_name>
      <phone>405-271-8787</phone>
      <email>Mikio-nihira@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Chermansky, MD</last_name>
      <phone>412-692-4096</phone>
      <email>Chermanskycj2@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greenville Health System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charles Marguet, MD</last_name>
      <phone>864-286-7570</phone>
      <email>cmarguet@ghs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Female Pelvic Medicine and Reconstructive Surgery Clinic</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Benson, MD</last_name>
      <phone>605-328-1368</phone>
      <email>Kevin.Benson@sanfordhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Dmochowski, MD</last_name>
      <phone>615-322-3807</phone>
      <email>Roger.dmochowski@vanderbilt.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Methodist Urology Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Timothy B Boone, MD, PhD</last_name>
      <phone>713-441-6458</phone>
      <email>Tboone3@tmhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Benaroya Research Institute at Virginia Mason</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Una Lee, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>206-223-6772 , Una.lee@vmmc.org</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 29, 2014</lastchanged_date>
  <firstreceived_date>July 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urinary Incontinence, Stress</keyword>
  <keyword>Tissue Therapy (Cell Therapy)</keyword>
  <keyword>Transplantation, Autologous</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
